Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02983006
Title Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors New York University School of Medicine



DS-8273a + Nivolumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Laura and Isaac Perlmutter Cancer Center New York New York 10016 United States Details
*Shaded cells indicate that there was no data available from for the field